Test and treat all as soon as possible. François Dabis - The Lancet Global Health
▻http://www.thelancet.com/journals/langlo/article/PIIS2214-109X(13)70178-5/fulltext?rss=yes
2013 will be remembered as an exceptional year in shaping our strategy to control HIV/AIDS. Indeed, a few weeks after the 30th anniversary of the discovery of the virus, a decisive step was made in deciding how to use antiretroviral therapy (ART) for treatment and prevention worldwide. New WHO public health guidelines recommended that ART should be started in all adults who reach a threshold of 500 CD4 cells per μL.1 These guidelines were based on a strict review process and on the grounds of clinical and epidemiological benefits. Yet their application at country level remains challenging and operational guidance is needed now the target population has expanded to almost 30 million people living with HIV.2